Quipt Home Medical Corp (QIPT): Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

This price chart for Quipt Home Medical (QIPT) shows an EV/EBITDA of 6.12, which is critical for expansion via the acquisition of small firms to compete with local networks. The business relies on stable demand for respiratory support, independent of crises and government insurance. Operations are based on strict quality control and the disinfection of ventilators within distribution centers.

Quipt Home Medical Inc. - QIPT Company Value to EBITDA (period 11/23/2025 - 03/28/2026)

Metric breakdowns and analytics for quipthomemedical.com (QIPT)

- current price and projected stock value:

Stock Price Quipt Home Medical Inc.|QIPT - Analyst Consensus Forecast

- stock exchange capitalization data:

Market Value Quipt|QIPT - Business Value

- book value of equity indicators:

Book Value per Share Quipt Home Medical|QIPT - Total Stockholders' Equity|Market Value to Book Value Ratio quipthomemedical.com|QIPT - Company Assets

- company total debt and liquidity indicators:

- financial results and valuation multiples details:

QIPT - Company Net Income|Projected Future Earnings Quipt Home Medical|QIPT - Price to Earnings Multiple|Forward P/E Multiple Quipt Home Medical|QIPT - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Quipt|QIPT - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Quipt Home Medical|QIPT - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months quipthomemedical.com|QIPT - Earnings per share growth in current year|Expected earnings per share growth for next year Quipt Home Medical

Comprehensive company analysis:Quipt Home Medical Inc. (QIPT)

Manufactured products of Quipt Home Medical Corp.

The operational efficiency of Quipt Home Medical (QIPT) during its expansion period is directly reflected in the EV/EBITDA multiple trend. This metric compares the total enterprise value of the business, including debt, against its annual earnings before interest, taxes, depreciation, and amortization. Such an approach allows for an assessment of the real value of assets burdened by loans used for acquisitions. A decline in this ratio may signal either an undervaluation or a critical liquidity shortage.

Key competitors

EV/EBITDA Multiple SYK (Stryker Inc)|EV/EBITDA Multiple Medtronic Corp MDT|PHG - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SNN (smith-nephew.com) - Enterprise Value to Operating Income Before Depreciation|HOLX: EV/EBITDA Multiple|Company Value to EBITDA Carlisle Companies Incorporated (CSL)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Greatbatch|Company Value to EBITDA LivaNova Corp LIVN|Enterprise Value to EBITDA Ratio AHCO (AdaptHealth Corp.)|EV/EBITDA Multiple SS Innovations International, Inc. (SSII)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avanos Medical AVNS|Total Company Value to Operating Income Before Depreciation Ratio Shoulder Innovations, Inc. (SI)|VMD: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation INGN (Inogen, Inc.)|owletcare.com (OWLT) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Precision Optics Corporation|PAVM (PAVmed, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA Tivic Health Systems, Inc. TIVC|EV/EBITDA Multiple MOVE|Nuvo Group Ltd - Enterprise Value to Operating Income Before Depreciation